GSK Alerts Public to Tampering of OTC Weight Loss Drug

GlaxoSmithKline alerted consumers that five lots of its OTC weight loss drug Alli may have been tampered with after fielding complaints that a different drug was in some of the bottles. GSK is recalling all lots of the drug from the U.S. and Puerto Rican markets, and said Wednesday it started an investigation alongside the FDA.
Drug Industry Daily